181 related articles for article (PubMed ID: 21085072)
1. Surveillance for colorectal cancer in patients with inflammatory bowel disease.
Hurley JJ; Turner J; Berrill J; Swift G; Dolwani S; Green J
Br J Hosp Med (Lond); 2010 Oct; 71(10):562-7. PubMed ID: 21085072
[No Abstract] [Full Text] [Related]
2. Endoscopy/surveillance in inflammatory bowel disease.
Ahmadi AA; Polyak S
Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
[TBL] [Abstract][Full Text] [Related]
3. Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.
Munkholm P; Loftus EV; Reinacher-Schick A; Kornbluth A; Mittmann U; Esendal B
Digestion; 2006; 73(1):11-9. PubMed ID: 16410688
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice.
Verschuren EC; Ong DE; Kamm MA; Desmond PV; Lust M
Intern Med J; 2014 Jan; 44(1):40-9. PubMed ID: 24015799
[TBL] [Abstract][Full Text] [Related]
5. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
6. Does monitoring prevent cancer in inflammatory bowel disease?
Loftus EV
J Clin Gastroenterol; 2003; 36(5 Suppl):S79-83; discussion S94-6. PubMed ID: 12702971
[TBL] [Abstract][Full Text] [Related]
7. "Doctor, I just can't": nonadherence to surveillance colonoscopy.
Kane S
Inflamm Bowel Dis; 2013 Mar; 19(3):540-1. PubMed ID: 23429445
[No Abstract] [Full Text] [Related]
8. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for cancer and dysplasia in inflammatory bowel disease.
Rubin DT; Kavitt RT
Gastroenterol Clin North Am; 2006 Sep; 35(3):581-604. PubMed ID: 16952742
[TBL] [Abstract][Full Text] [Related]
10. [Tracing colorectal carcinoma in patients with inflammatory bowel disease].
de Jong DJ; Nagengast FM
Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2758-60. PubMed ID: 18232192
[TBL] [Abstract][Full Text] [Related]
11. Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ; Basseri B; Papadakis KA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
[TBL] [Abstract][Full Text] [Related]
12. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
13. Dysplasia surveillance - a practical guide.
Kariyawasam V
J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():31-2. PubMed ID: 27273037
[No Abstract] [Full Text] [Related]
14. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice.
Sanduleanu S; Kaltenbach T; Barkun A; McCabe RP; Velayos F; Picco MF; Laine L; Soetikno R; McQuaid KR
Gastrointest Endosc; 2016 Jan; 83(1):213-22. PubMed ID: 26364967
[No Abstract] [Full Text] [Related]
15. Inflammatory bowel disease and its association with colorectal cancer.
Schechter S
R I Med; 1995 Jun; 78(6):161-3. PubMed ID: 7626814
[No Abstract] [Full Text] [Related]
16. Surveillance strategies in inflammatory bowel disease.
Schmidt C; Bielecki C; Felber J; Stallmach A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
[TBL] [Abstract][Full Text] [Related]
17. Cancer in inflammatory bowel disease.
Bachwich DR; Lichtenstein GR; Traber PG
Med Clin North Am; 1994 Nov; 78(6):1399-412. PubMed ID: 7967916
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
19. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
Stange EF
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
[TBL] [Abstract][Full Text] [Related]
20. Reduction of colorectal cancer risk in patients with Crohn's disease.
Lichtenstein GR
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
